Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis

PURPOSE: The prognosis of patients with advanced and recurrent urothelial cancer (UC) is poor. Although cisplatin (CDDP)-containing chemotherapy is the most effective regimen in these patients, there is no other established chemotherapeutic regimen. We administered combination therapy with low-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyata, Yasuyoshi, Nomata, Koichiro, Ohba, Kojiro, Matsuo, Tomohiro, Sagara, Yuji, Kanetake, Hiroshi, Sakai, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428519/
https://www.ncbi.nlm.nih.gov/pubmed/22864875
http://dx.doi.org/10.1007/s00280-012-1938-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3428519/
https://www.ncbi.nlm.nih.gov/pubmed/22864875
http://dx.doi.org/10.1007/s00280-012-1938-3

Ejemplares similares